NCT07497490

Brief Summary

The goal of this study is to investigate the impact of integrating handheld abdominal ultrasound into the current gastroenterology and hepatology consultation model at our hospital, particularly in terms of the speed of diagnostic evaluation and the impact of hospital length of stay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

December 15, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

August 8, 2024

Last Update Submit

March 24, 2026

Conditions

Keywords

Handheld ultrasoundAbdominal diseasesGastrointestinal and hepatology consultationIn-patientHospita length of stay

Outcome Measures

Primary Outcomes (1)

  • Time to diagnostic imaging

    This outcome evaluates the clinical efficiency of the diagnostic workflow by measuring the time interval (in minutes) required to complete the initial diagnostic imaging. The exact measurement endpoints are defined by the study arm: Start point (Both arms): The exact time the gastroenterology consultation is initiated. End point (Intervention group): The execution of the point-of-care evaluation using the handheld ultrasound device (HUD) by the consultant at the bedside. End point (Control group): The execution of the first formally scheduled diagnostic imaging study (e.g., computed tomography \[CT\], magnetic resonance imaging \[MRI\], or conventional cart-based ultrasound) ordered as part of standard care following the consultation.

    From the initiation of the consultation to the execution of the diagnostic imaging study, assessed up to hospital discharge (an average of 14 to 30 days).

Secondary Outcomes (2)

  • Post-Consultation Hospital Length of Stay (LOS)

    From the initiation of the gastroenterology consultation to the date of hospital discharge, assessed up to a maximum of 1 year.

  • Diagnostic Accuracy of the Targeted Organ by Handheld Ultrasound Device (HUD)

    From the time of initial HUD evaluation up to hospital discharge (an average of 2 to 4 weeks).

Study Arms (2)

Handheld Ultrasound/POCUS Arm

EXPERIMENTAL
Diagnostic Test: Portable Ultrasound

Control Arm

NO INTERVENTION

Interventions

Portable UltrasoundDIAGNOSTIC_TEST

A handheld portable ultrasound sponsored by Aco Healthcare Co., Ltd company

Handheld Ultrasound/POCUS Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged over 18 who are hospitalized or in the intensive care unit.
  • Those requiring a gastroenterology consultation or abdominal ultrasound, including cases of abdominal pain, diarrhea, abnormal liver function, unexplained fever, or evaluating intra-abdominal vascular thrombosis.

You may not qualify if:

  • \- Patients unable to comply with handheld ultrasound examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 10002, Taiwan

Location

Related Publications (1)

  • Barreiros AP, Dong Y, Ignee A, Wastl D, Dietrich CF. EchoScopy in scanning abdominal diseases; a prospective single center study. Med Ultrason. 2019 Feb 17;21(1):8-15. doi: 10.11152/mu-1907.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2024

First Posted

March 27, 2026

Study Start

December 15, 2024

Primary Completion

July 31, 2025

Study Completion

November 30, 2025

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations